Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cotignola

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Biotechnology|November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate CancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology|April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Biomolecules|March 22, 2020
HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer ProgressionNicolás Anselmino, Juan Bizzotto, Pablo Sanchis, et al.
Oncotarget|June 26, 2014
Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cellsGeraldine Gueron, Jimena Giudice, Pia Valacco, et al.
Cancers|November 27, 2024
<i>AR</i> (CAG)<sub>n</sub> Microsatellite and <i>APEX1</i> c.444T>G (p.Asp148Glu) Polymorphisms as Independent Prognostic Biomarkers in Prostate Cancer: Insights from an Argentinian CohortGaston Pascual, Agustina Sabater, Juan Bizzotto, et al.
Communications Biology|January 23, 2021
The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancerSofia Lage-Vickers, Juan Bizzotto, Maria Pia Valacco, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts ProgressionAgustina Sabater, Pablo Sanchis, Rocio Seniuk, et al.
International Journal of Molecular Sciences|November 9, 2024
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven Seven-Gene Stemness Signature That Predicts ProgressionAgustina Sabater, Pablo Sanchis, Rocio Seniuk, et al.
BMC Medical Genetics|March 10, 2007
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanomaJavier Cotignola, Boris Reva, Nandita Mitra, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 InteractorsSofia Lage-Vickers, Pablo Sanchis, Juan Bizzotto, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Biotechnology|November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate CancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology|April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Biomolecules|March 22, 2020
HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer ProgressionNicolás Anselmino, Juan Bizzotto, Pablo Sanchis, et al.
Oncotarget|June 26, 2014
Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cellsGeraldine Gueron, Jimena Giudice, Pia Valacco, et al.
Cancers|November 27, 2024
<i>AR</i> (CAG)<sub>n</sub> Microsatellite and <i>APEX1</i> c.444T>G (p.Asp148Glu) Polymorphisms as Independent Prognostic Biomarkers in Prostate Cancer: Insights from an Argentinian CohortGaston Pascual, Agustina Sabater, Juan Bizzotto, et al.
Communications Biology|January 23, 2021
The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancerSofia Lage-Vickers, Juan Bizzotto, Maria Pia Valacco, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts ProgressionAgustina Sabater, Pablo Sanchis, Rocio Seniuk, et al.
International Journal of Molecular Sciences|November 9, 2024
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven Seven-Gene Stemness Signature That Predicts ProgressionAgustina Sabater, Pablo Sanchis, Rocio Seniuk, et al.
BMC Medical Genetics|March 10, 2007
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanomaJavier Cotignola, Boris Reva, Nandita Mitra, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 InteractorsSofia Lage-Vickers, Pablo Sanchis, Juan Bizzotto, et al.
Pageof 5